Respiratory panel 2.1 IVD, $4,050.00 x 40, rfit-ASY-0118-GSA- faiv kit, $5,676.68 x 6, rfit-ASY-0116-GSA- faiv kit, $4,562.53 x 34.

Ended Awarded Last action

Contract number
N0025921F0119
Awardee
Awarding agency
Obligated
$296,716

Award facts

Opportunity
Contract value 100% obligated
$296,715.74 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millcreek, UT 84107, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · The purpose of this modification is to modify the delivery quantity of the 06/30/2022 shipment of clin 0002 from 9 each to 5. -$18,250
Supplemental Agreement for work within scope P00004 · Modify clin 0004 structure. $0
Supplemental Agreement for work within scope P00003 · The purpose of this modification is to cancel the 03/09/2022 shipment of clin 0002 and change the 06/08/2022 shipment to 06/30/2022. -$36,500
Funding Only Action P00002 · The purpose of this modification is to add general fund enterprise business system (gfebs) funding. This contract is fully funded. $351,466
Other Administrative Action P00001 · Respiratory panel 2.1 IVD, 423742. Change delivery date under extended description for clin 0003 from 10/05/2021 to 01/26/2022. $0
Original award $0

About this award

This federal contract award to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods, was issued by the Defense Health Agency. The award covers the delivery of the Respiratory Panel 2.1 IVD test kits, the RFIT-ASY-0118-GSA-FAIV Kit, and the RFIT-ASY-0116-GSA-FAIV Kit, with a total potential value of $296,715.74. The contract was issued as a Delivery Order under the General Services Administration's (GSA) Multiple Award Schedule (MAS) and is priced on a Firm Fixed Price basis. There was no set-aside designation for this award, and the period of performance ends on September 1, 2022. This contract supports the Defense Health Agency's mission of providing medical capabilities to the U.S. Armed Forces.

Quick answers

Who was awarded contract N0025921F0119?

N0025921F0119 was awarded to Biofire Defense LLC by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2021.

How much is contract N0025921F0119 worth?

The government has obligated $296,716 on N0025921F0119.

Which agency awarded contract N0025921F0119?

Bureau of Medicine and Surgery (Department of the Navy) awarded N0025921F0119, with funding from Defense Health Agency (Department of Defense).

Is contract N0025921F0119 an order under another contract?

Yes. N0025921F0119 is a delivery order under 47QSWA18D009D, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract N0025921F0119 competed?

The extent of competition for N0025921F0119 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award